AMAG Pharma (NASDAQ: AMAG) has commenced an underwritten public offering of approximately $200 million of its common stock. AMAG intends ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE